Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

KY-455: Kyoto Pharm.'s ACAT/lipid peroxidation inhibitor

May 3, 1996

Vertex dedicates significant efforts to MDR-reversing agents

May 3, 1996

Eisai presents preliminary data on ER-34335

May 3, 1996

Selectin inhibitor GSC-150 effective in dermatitis models

May 3, 1996

MM-218 selected for development in emesis, diarrhea

April 26, 1996

OT-5226: New antidiabetic from Otsuka

April 26, 1996

Tanabe Seiyaku reports CCK-A antagonist for pancreatitis

April 26, 1996

Sanwa's SKK-47029 for disorders of gastric emptying

April 26, 1996

Terumo presents two new fibrinogen receptor antagonists

April 26, 1996

Japanese investigators reveal new agent for heart failure

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...